Back A A A Font Size Receive E-mail Alerts Press Releases

The Project "Research on a Minimal Invasive, High Efficiency Orthopedic Robotic System" Officially Launched in Shanghai


Shanghai, China – On June 28, the project "Research on a Minimal Invasive, High Efficiency Orthopedic Robotic System" was officially launched in Shanghai. The project was listed in the National Key Research & Development ("R&D") Plan, falling into the category of "Digital Diagnostic Equipment R&D." It is a four-year project co-developed by Suzhou MicroPort OrthoRecon Co., Ltd. ("MicroPort® OrthoRecon"), Shanghai Ninth People's Hospital of Shanghai Jiaotong University, Peking University, Beijing Institute of Technology, Third Military Medical University, Fudan University, and Shanghai Medical Device Testing Institute.

MicroPort® Chairman and Chief Executive Officer Dr. Zhaohua Chang attended and addressed the launching ceremony of the project. He said:" MicroPort® will continue to work with the R&D teams of the hospitals and institutions to jointly develop the orthopedic robotic system that would hopefully directly benefit the surgeons and patients." Academician Kerong Dai of Chinese Academy of Engineering and Professor Yan Wang, President Shanghai Ninth People's Hospital of Shanghai Jiaotong University, also delivered speeches to encourage the project team to develop the first orthopedic robotic system in China with lofty aspirations and unremitting efforts. The Principal Scientist of the project Director Huiwu Li of Shanghai Ninth People's Hospital of Shanghai Jiaotong University then briefly introduced the project, outlined the core tasks of each sub-project, and discussed about problems that may arise with leaders of the project co-developers to lay a solid foundation for its future development.

About MicroPort®

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 8 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Cardiac Rhythm Management, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to bringing about a people-centric SuperCluster of emerging medical technologies to provide the best yet accessible ways & means to prolong and reshape lives.

For more information, please refer to:

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 1998-2019 MicroPort Scientific Corporation

Leanne Li
Board Secretary and Vice President of Corporate General Affairs
MicroPort Scientific Corporation
Tel: (86)(21) 38954600-6957


[Prev]:MicroPort® Orthopedics Hosts US-Chinese Surgeons Academic Exchange Program
[Next]:MicroPort® NeuroTech Attends CSA & TISC 2017